First RayStation® order in the United Kingdom

RaySearch Laboratories AB (publ.) has been awarded a contract to supply its
RayStation® treatment planning system (TPS) to Tayside Cancer Centre, Ninewells
Hospital & Medical School in Dundee, UK. Ninewells will be the first clinical
installation of RayStation® in the United Kingdom.
Ninewells Hospital & Medical School is one of the largest teaching hospitals in
Europe. It has a comprehensive regional cancer centre serving the Tayside region
of Scotland. The centre offers all forms of cancer therapy and treats
approximately 1400 new cancer patients annually. The radiotherapy department at
Ninewells will replace its current TPS with RayStation®, as its treatment
planning system for conventional 3D-CRT treatments, as well as more advanced
treatments, such as IMRT and VMAT.

The order includes sophisticated solutions, such as multi-criteria optimization,
enabling a more efficient treatment planning process. Multi-criteria
optimization is a highly intuitive tool that lets the clinician evaluate the
impact of changing different treatment priorities in real-time, which has a
large potential to speed up the time-consuming plan optimization process. The
radiotherapy department at Ninewells Hospital will also implement dose tracking
and adaptive planning using the dedicated tools available in RayStation, as well
as investigating biological optimization and evaluation.

“NHS Tayside made the decision to purchase RayStation® following a comprehensive
NHS Scotland procurement and evaluation process. The process took into
consideration TPS generic specifications, site specific requirements by Tayside
Cancer Centre and the benefits the system will bring to the centre over and
above the competing systems. We look forward to working with the RaySearch team
to produce the best possible treatment plans for patients”, says Salam Souliman,
Head of RT Physics at Ninewells Hospital.

“The UK is a highly important market for us. We established our UK sales and
service office in the second half of 2013 and this has already resulted in the
first customer order. Ninewells is an excellent clinic and we are of course
thrilled that they have now become our first UK customer”, says Johan Löf CEO of
RaySearch.

About RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
photon, electron and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch’s
products are mainly sold through license agreements with leading partners such
as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been
launched through partners and RaySearch’s software is used at over 2,300 clinics
in more than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was founded
in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is
listed in the Small Cap segment on NASDAQ OMX Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ.)
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com